ABSTRACT CYBULSKA, JANINA (State Institute of Hygiene, Warsaw, Poland), AND J. JEL-JASZEWICZ. Bacteriostatic activity of serum against staphylococci. J. Bacteriol. 91:953-962. 1966.-Antistaphylococcal activity of normal serum against strains exhibiting various patterns of coagulase, clumping-factor, and staphylokinase production is not connected with the presence of these factors. Purified coagulase does not influence this property of serum. Coagulase-negative strains with clumpingfactor activity grow in normal serum as typical pathogenic staphylococci. Serum bacteriostatic activity against staphylococci may be reversed by several nonspecific factors, such as sterile broth, supernatant fluids of coagulase-negative strains, and ammonium sulfate precipitates of culture supernatant fluids of various staphylococci. Immune sera with a high agglutinating titer for staphylococcal cells do not prevent growth of serum-resistant strains; serum-susceptible strains are inhibited as in normal serum control. Activation or blocking of the serum fibrinolytic system does not influence serum bacteriostatic activity. The growth rate of serum-resistant strains is identical in serum and in Todd-Hewitt broth; serum-susceptible strains are inhibited to the inoculum level, but decreases and increases in viable count are noted during a 24-hr observation period. Observations made with sera of 10 animal species clearly demonstrated differences in serum bacteriostatic activity, mouse serum being completely noninhibitory and cat serum only weakly inhibitory. The technique of quantitative determination of serum susceptibility of staphylococci is described, and the importance of serum antistaphylococcal activity in vitro is discussed. Experimental staphylococcal infection produced in rabbits by intravenous injection of different Staphylococcus aureus strains did not result in significant changes in serum antistaphylococcal activity. The technique of experimental infection used caused chronic infection, with a peak on the 14th day; this was proved by means of a newly developed 5'-nucleotidase test. At the same time, sera of infected animals exhibited slight inhibitory properties, which returned to initial values 1 week later. Infection was produced by strains recognized as nonpathogenic and was inhibited in vitro by sera from both normal and infected rabbits. It is concluded that antistaphylococcal activity of serum should be considered as an "in vitro" phenomenon, which seems to have no importance in defense mechanisms of rabbits infected intravenously with staphylococci.
Coagulase-positive strains of Staphylococcus aureus isolated from pathological material multiply readily in normal human serum, whereas nonpathogenic strains are inhibited (19, 20, 21) . This phenomenon was found to be independent of complement and lysozyme and to be produced by a thermostable factor present in fresh serum (8, 18) . Resistance of pathogenic staphylococci to the action of normal sera has aroused interest in the mechanism of nonspecific resistance to infection by these strains, especially after presentation 953 of a hypothesis on reversing of serum antistaphylococcal activity by coagulase (5) . According to Ekstedt (3, 4) , this activity depends on the presence of a thermostable serum factor which is neutralized by coagulase. Coagulase is supposed to activate respiration of staphylococci, and when adsorbed on coagulase-negative cells, prevents their destruction by the serum (6) . The active factor was found in the globulin fraction of nor-CYBULSKA AND JELJASZEWICZ This role of coagulase was, however, not confirmed (23, 24) and was also more or less doubtful to other investigators (9, 15, 18) . It is not known whether serum of an animal infected with staphylococci exhibits bacteriostatic activity in vitro.
This communication is concerned with antistaphylococcal activity of normal sera derived from 10 animal species and the influence of various factors including coagulase on this phenomenon in vitro. Bacteriostatic activities of sera derived from rabbits infected with eight strains of S. aureus and with single strains of Streptococcus pyogenes and Escherichia coli were observed and compared.
MATERIALS AND METHODS
Strains. Characteristics of the 12 strains of S. aureus used are given in Tables 2 and 3 . The sources of the strains were as follows: strain Smith (diffuse and compact variants) was received from D. E. Rogers; 8447-B from D. D. Smith; Newman D2C, A-224, and E-7 from E. S. Duthie; Jacherts from D. Jacherts; Mendita from S. I. Morse; strain Czerszer was isolated by us from the nose of a child during an epidemic of staphylococcal enterocolitis in Katowice hospital; strain Zak was isolated from a case of conjunctivitis occurring in this laboratory; Kulba was from the blood of a patient with staphylococcal bacteremia in Warsaw University Dermatological Clinic; and Bekasiak was isolated from the nose of a child with scarlet fever in Poznan Children's Hospital for Infectious Diseases.
The following strains of S. aureus were used for animal experiments: Smith compact and diffuse, E-7, Bekasiak, 8447-B, Jacherts, Mendita, and Newman D2C. Infections with Streptococcus pyogenes (type 15) and E. coli 0:26 were made for control and comparative purposes.
Production of toxins. Coagulase was determined at 20 and 37 C with 10 plasmas of the various species used in these experiments; fresh citrated plasma diluted 1:5 with saline was used. Results were read after 1, 3, 6, and 24 hr. Clumping factor (or bound coagulase) was tested with undiluted plasma. The details have been described elsewhere (13 Growth ofstaphylococci in serum and broth. Growth curves of typical staphylococcal strains in normal rabbit serum and Todd-Hewitt broth were prepared. Smith compact variant, multiplying readily in serum, and strain Mendita, which is inhibited in its growth, were chosen. Measurements were made in duplicate serum and broth samples. Viable counts were calculated in samples taken every 2 hr during a 24-hr period. Viable counts and determination of bacteriostatic activity of serum were performed as described below.
Plasma samples. Heart blood was drawn into sodium citrate solution from rabbits, mice, guinea pigs, rats, and cats, and venous blood from humans, sheep, horses, dogs, and roosters. Pools of samples derived from several individuals were used on the same day.
Serum samples. Blood samples were kept for 1 hr at 37 C and then 1 hr at 4 C. Serum was removed, centrifuged if necessary, and then pooled with similar sera from several animals. It should be stressed here that sera were always used within a few hours, i.e., the same day that they were collected. All tests were started at physiological pH.
Collection of blood from infected rabbits for determination ofserum antistaphylococcal activity. Samples of blood were taken from the heart before infection, and then on the 7th, 14th, and 21st day after the first infection. Every sample of serum was tested quantitatively for its bacteriostatic activity against the Mendita (inhibited in normal sera) and Smith compact (multiplying in normal sera) strains.
Determination of bacteriostatic activity of serum. Measurements were carried out with 0.5-ml volumes of sera in Pyrex serological test tubes closed with rubber stoppers. The inoculum was prepared as follows. An 18-hr Todd-Hewitt broth culture was centrifuged, the sediment was thoroughly suspended in 5 ml of saline, and was then diluted 1,000-fold with saline. Volumes of 0.1 ml of the diluted suspensions were added to each test tube containing 0.5 ml of serum; 0.2 ml of suspension was added to the tube containing 1 ml of saline. Serum samples were incubated at 37 C in a water bath for 24 hr. The test tubes with saline only served for the initial viable-count calculation. For this purpose, the suspension was diluted 10-1, 10-2, and 10-s, and 0.5-ml portions were transferred onto sheep blood-agar plates and spread with a sterile glass rod. The blood-agar plates had been dried at 37 C for 2 hr. Inoculated plates were incubated at 37 C overnight, and the viable count was calculated. The inocula prepared in this manner are reproducible. After incubation, serum samples inoculated with staphylococci were thoroughly shaken, since some strains grow in serum as a dense granular sediment. Samples (0.5 ml) were withdrawn from each tube. Readily visible bacterial growth suggested dilution of 106 to 108, and absence of turbidity, 101 to 105. The samples were then inoculated onto blood-agar as described for inoculum, with the use of four plates for abundantly growing strains and five plates for strains which did not produce serum turbidity. It Staphylokinase. Purified and concentrated staphylokinase was prepared as described by Glanville (11) . Solutions of initial concentration of 5 mg/mi were sterilized by filtration through Schott G-5 filters and used in a final concentration of 500 ,g/ml of serum. A 1-mg amount of the staphylokinase sample contained 1,200 caseinolytic units. Serum with added staphylokinase was preincubated for 30 min at 37 C.
Complement. A commercial product (Lublin, Sera and Vaccines Laboratory) was used. The contents of the ampoule, corresponding to 2 ml of guinea pig serum, were dissolved in 1 Todd-Hewitt broth. The broth was prepared in the conventional manner. Broth (10 or 30%) was added to serum, incubated for 30 min at 37 C, and used for control determinations.
Reversal of serum bacteriostatic activity by coagulase. Sterile coagulase, purified as described above, was added directly to the serum to achieve a final concentration of 2 mg/ml of serum. After the coagulase dissolved, serum samples were preincubated for 1 hr at 37 C.
Immune sera. Rabbits were immunized with formalinized and heat-killed suspensions of staphylococci by intravenous injections, as described for preparation of streptococcal grouping sera (Rockefeller Institute Hospital procedure). Sera agglutinating with homologous suspensions in dilutions higher than 1:600 were obtained.
Experimental infection. Rabbits of both sexes, received from a commercial source and weighing 2,500 to 3,000 g, were used. It was established that intravenous injection of rabbits with a dose of about 6 X 105 to 10 X 105 staphylococcal cells, followed by injection of a 10-fold higher dose after 6 days, results in chronic staphylococcal infection with final localization in kidneys, and pyelonephritis (Piekacz, Jeljaszewicz, and Zak, in preparation). Groups of six rabbits were infected by injection into the marginal ear vein of suspensions of viable staphylococci at the concentrations indicated in Table 1 .
Histochemical determination of S'-nucleotidase activity in leukocytes. This was performed by the technique described by Wachstein and Meisel (23) . Results were expressed as percentages of cells with enzyme activity.
RESULTS
Strains with different properties were selected for the purposes of this study. They differed in phage patterns, antibiotic sensitivity, and production of coagulase, clumping factor, and staphylokinase (Tables 2 and 3 ).
In the preliminary experiments, strains differing in regard to coagulase production were selected. (Fig. 1) . Therefore, the overall effect of the inhibitory activity of serum against tested strains of S. aureus, after 24 hr of incubation, should be considered as bacteriostatic rather than bactericidal.
Species differences in serum bacteriostatic activity were noted (Table 4) . Mouse serum showed complete lack of antistaphylococcal activity against all studied strains. Although the growth indexes of strains Mendita and 8447-B were lower than with the remaining strains, growth was nevertheless very distinct. Opposite results were achieved with the rooster serum. Growth of staphylococci was strongly inhibited even in the case of Bekasiak and Jacherts strains, which multiplied abundantly in other sera. It should be mentioned here that coagulase-negative strains exhibiting the clumping factor activity grew in serum as did typical coagulase-positive staphylococci.
The Kulba strain, coagulase-and clumping factor-negative with all 10 plasmas used, was the only strain of such type which exhibited moderate growth in human and rabbit serum. The E-7 strain, of animal origin, was strongly inhibited by human and rabbit serum, but grew in several other sera. Cat serum was found to be weakly bacteriostatic for staphylococci, inhibiting only the Zak strain. Very similar results were obtained with human, rabbit, guinea pig, and dog plasma.
No correlation was found between excretion of coagulase, clumping factor, or staphylokinase, and the ability of a given strain to multiply in serum (Table 5) .
Purified coagulase did not change the growth index of serum-susceptible strains of staphylococci (Table 6 ). Reversal of serum antistaphylococcal activity could be achieved, however, by several simple procedures. It was shown that supernatant fluids of staphylococcal cultures, whether coagulase-positive or -negative, could reverse the serum antistaphylococcal activity. Examples of such data are presented in Fig. 2 The observed phenomenon of serum antistaphylococcal activity does not seem to be a simple immunological mechanism. Serum-susceptible strains were still inhibited in immune sera, whereas serum-resistant strains grew as easily as in normal sera ( Table 7) . Addition of complement to mouse serum does not change its activity toward staphylococci (Table 8) . It lytic activity. The antistaphylococcal serum system was also unaffected by the presence of EDTA.
Rabbits were infected with different strains of staphylococci: three of the strains used (E-7, VOL. 91, 1966 Mendita, and 8447-B) were inhibited in vitro by sera of healthy animals, whereas five others grew abundantly.
Staphylococcal infection in rabbits does not significantly influence serum antistaphylococcal activity, which is the same as in sera of normal animals. Regardless of whether infection was with a growing strain or with one inhibited in normal serum in vitro, the test strain Smith compact grew easily, whereas strain Mendita was still susceptible to the action of serum derived from the infected rabbit. Virtually identical results were obtained with all strains used for infection and all serum samples. A typical example is given in Fig. 4 . Intravenous infection with Streptococcus pyogens ard Escherichia coli also produced no changes in the studied phenomenon (Fig. 5) .
Near Hirsch (12) and Des Prez et al. (2) , to study the release of bactericidins from platelets after their damage, which occurs also during physiological clotting.
Experimental straphylococcal infection evoked in rabbits by the intravenous route does not result in significant changes in serum antistaphylococcal activity of these animals. The same applies to infection caused by Streptococcus pyogenes and Escherichia coli. Sera from infected animals, like sera from healthy rabbits, are inhibitory for serum-susceptible staphylococci, whereas pathogenic strains multiply rapidly.
The slower multiplication rate of staphylococci in sera of rabbits taken 2 weeks after infection, together with the increase in the number of polymorphonuclear leukocytes with 5'-nucleotidase activity, may suggest that this moment presents the peak of mobilization of defense mechanisms and infection progress. After the 14th day of experimental infection, both growth index and leukocyte 5'-nucleotidase activity return to the initial value. It has been recently proposed that number of polymorphonuclear leukocytes with 5'-nucleotidase activity may be considered as a measure of staphylococcal and streptococcal infection (Szmigielski, Jeljaszewicz, and Wilczynski, Pathol. Microbiol., in press).
Bacteriostatic activity of serum against some strains of staphylococci seems to present one of the nonspecific resistance factors. Its importance, however, is doubtful, at least in experimental staphylococcal infection of the rabbit. It should be noted also that, by the method of infection used, strains of S. aureus recognized as nonpathogenic on the basis of all bacteriological criteria and inhibited in serum in vitro (Mendita and 8447-B) caused pyelonephritis in rabbits.
Bacteriostatic activity of serum against staphylococci should be rather considered as an "in vitro" phenomenon, which may be helpful for indirect laboratory recognition of "pathogenic" and "nonpathogenic" staphylococci. This may be done by a recently described plate test (Cybulska and Jeljaszewicz, J. Chin. Pathol., in press), by means of which classification of pathogenic strains may be as easy as by the coagulase test. It should be mentioned here that some coagulasenegative strains are responsible for infections and, as shown in this communication with a Kulba strain, only detection of its moderate resistance to the action of serum enabled the differentiation of this strain from other coagulase-negative staphylococci. Antistaphylococcal activity of serum seems to have no importance in defense mechanisms of rabbits infected intravenously with staphylococci. Its 
